InsidersTradesSigma
Explore the detailed record of transactions filed by Davis Thomas Andrew, Directeur Médical. Insider active across 1 companies, notably Genocea Biosciences, INC.. In total, 2 reports have been published. Total volume traded: €1k. The latest transaction was filed on 4 April 2022 (Cession). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations
Thomas Andrew Davis is the Chief Medical Officer at Genocea Biosciences, Inc. He is responsible for leading the company's medical and scientific initiatives. With expertise in biotechnology, Thomas Andrew Davis plays a key role in developing new therapies and optimizing clinical processes. His commitment to innovation and research is essential for Genocea's success.